Produktinformation
- N1,N3,N5-Tris(2-hydroxyethyl)-1,3,5-benzenetricarboxamide
- LM 22A4
- N,N′,N′′-Tris(β-hydroxyethyl)trimesamide
- 1,3,5-Benzenetricarboxamide, N,N′,N′′-tris(2-hydroxyethyl)-
- 1,3,5-Benzenetricarboxamide, N1,N3,N5-tris(2-hydroxyethyl)-
LM22A-4 is a monoclonal antibody that binds to the neurotrophic factor nerve growth factor (NGF) and prevents it from activating its receptor. LM22A-4 has been shown to have neuroprotective effects in vivo, and can be used to treat neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. Additionally, LM22A-4 has been shown to promote neuronal function by increasing energy metabolism and mitochondrial biogenesis in vitro. The molecule also has immunomodulatory properties that may help with inflammatory conditions such as arthritis or asthma.
LM22A-4 is an antibody that was generated from a mouse immunized with human NGF. It binds to the natural compound NGF and prevents it from activating its receptor. LM22A-4 has been shown to have neuroprotective effects in vivo, and can be used to treat neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and
Chemische Eigenschaften
Technische Anfrage zu: 3D-MBA98818 LM22A-4
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
